Ocugen Inc. (NASDAQ: OCGN) is a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to fight COVID-19.
Sutro Biopharma
3 followers
Active Motif
3 followers
Dyno Therapeutics
4 followers
Janux Therapeutics
2 followers
Eikon Therapeutics
4 followers
Gilead Sciences
206 followers
Regeneron
178 followers
Illumina
90 followers
Agilent Technologies
98 followers
Verily Life Sciences
49 followers
Alexion Pharmaceuticals
56 followers